Graft and ossicular support
Supports the tympanic membrane graft during the critical healing phase, maintains ossicular chain position in mastoid cavities and prevents adhesions between the lateral graft and the medial bony walls.

A 100% fragmentable dressing for middle ear and mastoid cavity procedures: tympanoplasty, mastoidectomy and combined procedures.
Request samples or a trialVelnez is a 100% fragmentable sponge matrix specifically developed for middle ear and mastoid cavity procedures. It provides gentle, sustained support for the tympanic membrane graft and helps maintain the position of ossicular structures, without displacement pressure.
In the middle ear, the matrix combines structural support with haemostatic action and controlled degradation in situ.
Supports the tympanic membrane graft during the critical healing phase, maintains ossicular chain position in mastoid cavities and prevents adhesions between the lateral graft and the medial bony walls.
Helps achieve haemostasis at the bleeding surface, reduces clotting time and supports healing.
100% fragmentable, degrading in situ with no manual removal. Residual material comes away in a discharge form and is cleared during routine post-operative care, leaving a clean surgical site for assessment.
Square and rectangular configurations for middle ear and mastoid cavities.
For illustration only, not actual size.
REF codes are the manufacturer’s product references. NHS Supply Chain purchase codes will be added when available.
CE 2460 · Store at 4–30°C
One study has been published, in January 2024. Twenty-one patients were followed through ear surgery at a single centre in Agra, India. It was sponsored by the manufacturer, it carried no comparator group, and its authors name both the sample size and the single-arm design as limitations. It is peer reviewed and open access. It describes how Velnez behaved in the ear. It does not establish how it performs against any other pack.
Open-label, interventional, single-arm post-marketing surveillance study at a single centre. Twenty-one patients aged 18 to 60, followed over eight visits to sixty days. Velnez was used in two places in the same patients: minced within the middle ear to support the temporalis fascia graft, and as a space-occupying dressing in the external auditory canal.
The authors report that the pack disintegrated within the middle ear over an average of twenty-five days, confirmed on MRI, with no residual material found. Haemostasis was achieved within ninety seconds in every patient. No pack migrated, no infection was recorded, and no patient reported moderate pain at any visit through to day sixty.
The study was sponsored by Datt Mediproducts, the manufacturer. Conflicts of interest are disclosed in full under ICMJE, and the authors declare no financial relationships of their own. Ethics approval from Sarojini Naidu Medical College, Agra, with registration in the Indian national clinical trial registry. Patients taking anticoagulants or antiplatelet drugs, and those with diabetes or hypertension, were excluded, so the study reports nothing about those groups. The paper does not identify which Velnez sizes were used.
Singh AP, Singh S, Malik R. Cureus 2024;16(1):e51732.
Read the paper in full
Produced by Velnez, the product leaflet is the definitive clinical reference for this dressing, including detail not summarised on this page. Open it to view or download.
No. Velnez is 100% fragmentable, so there is no manual pack removal. Residual material is cleared during routine post-operative care, leaving a clean surgical site for assessment.
It fragments naturally in situ. As it degrades, material comes away from the middle ear to the outer ear cavity in a discharge form, and any residuals are cleaned during routine post-operative care.
Middle ear and mastoid cavity procedures: tympanoplasty, mastoidectomy and combined procedures. It supports the tympanic membrane graft during healing, maintains ossicular chain position and prevents adhesions between the lateral graft and the medial bony walls.
At ambient temperature (4–30°C). Velnez is single use, sterile and gamma irradiated.
Get in touch to request samples or organise a trial. Velnez is available directly from LP Med, with NHS Supply Chain listing to follow.
Velnez is manufactured by Datt Mediproducts Private Limited. DMP is their mark.